# Neuroscience-based nomenclature (NbN): the Portuguese version of the new classification for psychopharmacological drugs

## TL;DR

This paper introduces a new classification system for psychopharmacological drugs based on neuroscience and pharmacology to improve treatment and reduce stigma.

## Contribution

The paper presents the Portuguese version of the Neuroscience-based nomenclature (NbN) system for psychopharmacological drugs.

## Key findings

- NbN classifies drugs based on their mechanism of action and pharmacological target.
- NbN is endorsed by psychiatric associations and adopted by major journals and textbooks.
- The Portuguese version of NbN is introduced to increase its adoption among psychiatrists.

## Abstract

Neuroscience-based nomenclature (NbN) is a proposal to provide a nomenclature based on neuroscience and pharmacology instead of the old disease-based classification. The NbN is based on the mechanism of action and pharmacological target and aims to assist in rational prescription, to reduce stigma, and to increase treatment adherence. Currently, the NbN is endorsed by many psychiatric associations, has been adopted by several relevant journals, and is included in major psychiatry textbooks. Therefore, it is important that the NbN is known to psychiatrists.